- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07944014
Portfolio Diet for Dyslipidemia: A Hong Kong Pilot Study
Feasibility Study of a Health Education Programme to Improve Portfolio Diet Adherence for Hong Kong Adults With Dyslipidemia
Background:
Dyslipidemia (raised blood cholesterol) is a widespread public health concern in Hong Kong. While medications like statins are commonly used, many individuals hesitate to take them, making effective dietary strategies essential for reducing cardiovascular disease risk. The Portfolio Diet is a proven plant-based dietary pattern that can significantly lower cholesterol levels, but its feasibility has not yet been thoroughly explored or culturally adapted for a non-Western population like Hong Kong.
Purpose:
This feasibility study aims to evaluate whether a culturally tailored Portfolio Diet health education programme is practical, acceptable, and effective for Hong Kong adults with dyslipidemia. The findings will help researchers understand the practical challenges and motivators participants face when trying to change their diet, which will guide the design of a future larger-scale trial.
Methods:
A total of 12 Chinese adults aged 18 to 65 with borderline or high total cholesterol will participate in a 4-week health education programme. The programme begins with a group session explaining the core dietary principles, followed by 3 weekly individual dietary consultations with a research dietitian. The diet plan and sample 7-day menus are culturally adapted to include food items commonly consumed in Chinese culture.
Participants' diet adherence will be assessed using 3-day dietary records at the beginning and end of the study. Additionally, researchers will track feasibility data such as recruitment and retention rates, session attendance, and the completeness of the dietary records. Following the 4-week programme, participants will join focus group interviews to share their personal feedback, experiences, and suggestions for improving the programme for long-term use.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Background and Rationale:
Dyslipidemia is a major public health challenge in Hong Kong, affecting over half of the adult population. While standard management relies on lifestyle advice and pharmacotherapy (e.g., statins), patient hesitancy toward medication remains a significant barrier. The Portfolio Diet-a dietary pattern combining four cholesterol-lowering components (viscous fibers, plant sterols, plant proteins, and nuts)-has demonstrated clinical efficacy in reducing serum low-density lipoprotein-cholesterol (LDL-C) by a mean of 28.6% in Western cohorts. However, its feasibility, acceptability, and efficacy signal have not been explored in non-Western populations whose local dietary habits differ significantly. This feasibility study is a necessary prerequisite to adapt the dietary components into Chinese culture and inform the design of a future full-scale randomized controlled trial (RCT).
Objectives:
- To evaluate the feasibility and process metrics (recruitment, retention, and session attendance rates) of a culturally adapted Portfolio Diet health education programme.
- To assess the acceptability and participant burden (completion and compliance rates of 3-day dietary records).
- To explore the preliminary efficacy signal of the programme in improving Portfolio Diet adherence among Hong Kong adults with dyslipidemia.
- To identify facilitators and barriers to dietary change through qualitative feedback to enhance the future intervention plan.
Study Design and Interventions:
This is an interventional feasibility study utilizing a single-group, pre-post test design combined with a qualitative component. Twelve eligible Chinese adults with dyslipidemia will undergo a 4-week health education programme:
- Week 1 (Group Session): Introduction to the principles of the Portfolio Diet, its cholesterol-lowering mechanisms, and its relationship with cardiometabolic health.
- Weeks 2-4 (Individual Consultations): Three weekly sessions of personalized dietary consultations conducted by a research dietitian. Participants will receive a culturally tailored 7-day menu adjusted to commonly consumed food groups in Chinese culture, targeting five dietary pillars: nuts/seeds (45 g/day), plant protein (50 g/day), viscous fiber (20 g/day), plant sterols (2 g/day), and monounsaturated fatty acid-rich plant fats (45 g/day).
Qualitative Component:
Post-intervention, all 12 participants will be divided into two focus groups (6 participants per group) for a 1-hour semi-structured interview conducted by a trained research assistant. The interviews will be audio-recorded and will systematically explore four domains: programme acceptability, dietary changes and practicality, perceived benefits, and suggestions for long-term implementation in Hong Kong.
Data Collection and Dietary Analysis:
Quantitative clinical and socio-demographic data will be collected at baseline and at week 4 (post-intervention). Dietary adherence will be assessed using 3-day dietary records (2 weekdays and 1 weekend day) completed at both time points. Nutrient and individual component intakes will be rigorously analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0, ESHA Research), utilizing localized food composition tables from China and Hong Kong to ensure accuracy.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Ka-hei Kenneth Lo, PhD
- Telefonnummer: +852 3400 8778
- E-post: kenneth.kh.lo@polyu.edu.hk
Studiesteder
-
-
-
Hong Kong, Kina
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University
-
Ta kontakt med:
- Ka-hei Kenneth Lo, PhD
- Telefonnummer: +852 3400 8778
- E-post: kenneth.kh.lo@polyu.edu.hk
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Aged 18-65 years.
- Of Chinese ethnicity.
- Diagnosed with borderline or high total cholesterol (TC ≥ 5.2 mmol/L).
- Overweight or obese, defined as a Body Mass Index (BMI) ≥ 23 kg/m2.
- Currently residing in Hong Kong with no travel plans for the following 12 weeks.
- Able and willing to maintain a regular lifestyle and eating habits throughout the study period.
- Capable of providing voluntary written informed consent.
Exclusion Criteria:
- Known history of alcohol, cigarette, or drug abuse within the past 3 months.
- Known liver and/or renal dysfunction.
- Known history of severe medical conditions (e.g., cardiovascular disease, diabetes, inflammatory bowel disease, cancer, or psychiatric illness).
- Participation in any other interventional clinical trials within the past 3 months.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Portfolio Diet Education Group
A single group of 12 Hong Kong Chinese adults with dyslipidemia who receive a culturally adapted 4-week Portfolio Diet health education programme, followed by qualitative focus group interviews. |
The programme consists of 4 weekly sessions. Week 1 is a group-based session introducing the principles of the Portfolio Diet and its clinical relationship with cardiometabolic health. Weeks 2 to 4 consist of 3 individual dietary consultations conducted by a research dietitian. The dietary components (nuts/seeds, plant protein, viscous fiber, plant sterols, and plant-based fats) are culturally adapted to commonly consumed food groups in Chinese culture. Participants receive a localized 7-day menu to help modify their diet. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Programme Retention Rate
Tidsramme: At the end of the 4-week intervention
|
The percentage of enrolled participants who successfully complete the entire 4-week health education programme. This metric is used to evaluate the feasibility of the study protocol and participant retention. |
At the end of the 4-week intervention
|
|
Change in Portfolio Diet Adherence Score
Tidsramme: Baseline and Post-intervention (Week 4)
|
Assessed by 3-day dietary records (covering 2 weekdays and 1 weekend day) to evaluate the change in participant adherence to the Portfolio Diet pillars. Nutrient and dietary component intakes will be analyzed using Food Processor Nutrition Analysis and Fitness software (Version 8.0) with localized food composition tables. |
Baseline and Post-intervention (Week 4)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Participant Acceptability and Perceived Barriers via Focus Groups
Tidsramme: Post-intervention (Week 4)
|
Evaluated through post-intervention qualitative focus group interviews (6 participants per group). A semi-structured interview guide will be used to explore four core domains: acceptability of the programme format/duration, dietary changes and practical challenges, perceived health benefits, and suggestions for long-term implementation. |
Post-intervention (Week 4)
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Metabolske sykdommer
- Lipidmetabolismeforstyrrelser
- Oppførsel
- Ernæringsmessige og metabolske sykdommer
- Behandlingsoverholdelse og etterlevelse
- Helseatferd
- Pasientens etterlevelse
- Pasientens aksept av helsehjelp
- Adherence -intervensjoner
- Medisinoverholdelse
- Hyperkolesterolemi
- Dyslipidemier
- Hyperlipidemier
- Helse utdanning
Andre studie-ID-numre
- HSEARS20260714006
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
As this is a small-scale pilot feasibility study (N=12) focused on evaluating protocol processes and cultural acceptability, individual participant data will not be made publicly available to protect participant privacy.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .